Mulai Investasi Crypto di INDODAX! 🚀
Daftar akun cepat melalui link referral resmi wahyudedik dan dapatkan cuan berlipat-lipat!
Cloud Hosting Murah & Terpercaya di IDCloudHost! 🚀
Daftar sekarang dan dapatkan GRATIS Rp 25.000 credit untuk hosting pertama kamu. Performa tinggi, support 24/7!
MPRO
MPRO
Rp8.500
Update: 10 jam yang lalu
Open
8.450
High
9.900
Low
8.400
Prev Close
8.450
Volume
6.7K
vs IHSG
+5.01%
Statistik Pasar
Posisi dalam 52-Week Range
Foreign Flow (Asing)
Net Hari Ini
+0.0
Buy
0.0
Sell
0.0
Belum ada data foreign flow.
Chart Teknikal
MPROTidak ada data OHLCV tersedia
Chart gagal dimuat
AI sebagai simplifier, bukan chart tool
Chart, indikator, dan drawing tools ada di TradingView di atas. AI di sini bertugas menyederhanakan — menjelaskan kondisi market dengan bahasa yang mudah dipahami, bukan memperumitnya.
Sinyal AI + Data Keuangan Lengkap
Unlock rekomendasi AI, data fundamental, dan foreign flow untuk MPRO.
Detail Indikator Teknikal Pro
Melihat detail analisa sinyal dari indikator MACD kustom, Bollinger Bands, RSI-14, dan persilangan SMA.
Riwayat Harga
170 data| Tanggal | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.500 | 6.7K |
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.500 | 6.7K |
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.500 | 6.7K |
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.500 | 6.7K |
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.500 | 6.7K |
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.500 | 6.8K |
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.525 | 5.6K |
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.525 | 5.6K |
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.525 | 5.6K |
| 08 Jun 2026 | 8.450 | 9.900 | 8.400 | 8.525 | 5.6K |
Berita Terkait
India's foreign policy 'severely compromised', claims Kharge in INDIA bloc meet; says 'crores being deprived of voting rights'
Congress president Mallikarjun Kharge criticized the Centre, alleging a compromised foreign policy a...
In an AI world, compromised security will lead to fraud: Matthew Driver
Mastercard says stronger cybersecurity, agent verification and consent frameworks will be critical a...
Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which...
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring
/PRNewswire/ -- A new study examining the role of continuous glucose monitoring (CGM) in the managem...
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
In TRIUMPH-1, participants on retatrutide 12 mg lost an average of 70.3 lbs (28.3%) over 80 weeks, w...
Horizon Technology Finance: Waiting For Improvements To Materialize (NASDAQ:HRZN)
HRZN trades at a 33% discount to NAV, reflecting persistent portfolio and earnings weakness despite...